Cheila Rocha

1.8k total citations · 1 hit paper
27 papers, 943 citations indexed

About

Cheila Rocha is a scholar working on Infectious Diseases, Virology and Immunology. According to data from OpenAlex, Cheila Rocha has authored 27 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 11 papers in Virology and 6 papers in Immunology. Recurrent topics in Cheila Rocha's work include SARS-CoV-2 and COVID-19 Research (13 papers), HIV Research and Treatment (11 papers) and COVID-19 Clinical Research Studies (5 papers). Cheila Rocha is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (13 papers), HIV Research and Treatment (11 papers) and COVID-19 Clinical Research Studies (5 papers). Cheila Rocha collaborates with scholars based in Germany, Portugal and United States. Cheila Rocha's co-authors include Stefan Pöhlmann, Markus Hoffmann, Nadine Krüger, Amy Kempf, Inga Nehlmeier, Luise Graichen, Anne Cossmann, Hans‐Martin Jäck, Sebastian Schulz and Georg M. N. Behrens and has published in prestigious journals such as Cell, Nature Communications and The EMBO Journal.

In The Last Decade

Cheila Rocha

26 papers receiving 935 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic

2021 557 citations Markus Hoffmann, Nadine Krüger et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cheila Rocha Germany	13	725	221	178	114	89	27	943
Janin Nouhin Cambodia	15	876 1.2×	227 1.0×	278 1.6×	93 0.8×	172 1.9×	32	1.1k
Daniela Fera United States	8	623 0.9×	248 1.1×	124 0.7×	142 1.2×	81 0.9×	9	868
Philip L. Tzou United States	12	959 1.3×	309 1.4×	265 1.5×	56 0.5×	105 1.2×	22	1.1k
Shan Su China	19	570 0.8×	279 1.3×	172 1.0×	320 2.8×	250 2.8×	45	1.1k
Maia Kavanagh Williamson United Kingdom	10	931 1.3×	384 1.7×	88 0.5×	166 1.5×	150 1.7×	13	1.3k
Bruna Marini Italy	14	735 1.0×	665 3.0×	227 1.3×	118 1.0×	107 1.2×	18	1.4k
Pinkus Tober‐Lau Germany	11	429 0.6×	158 0.7×	63 0.4×	72 0.6×	70 0.8×	27	581
Kaiming Tao United States	8	710 1.0×	237 1.1×	40 0.2×	52 0.5×	58 0.7×	13	863
Cong Zeng China	16	631 0.9×	285 1.3×	35 0.2×	125 1.1×	80 0.9×	35	928
Hyejin Yoon United States	11	314 0.4×	196 0.9×	116 0.7×	90 0.8×	110 1.2×	16	596

Countries citing papers authored by Cheila Rocha

Since Specialization

Citations

This map shows the geographic impact of Cheila Rocha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheila Rocha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheila Rocha more than expected).

Fields of papers citing papers by Cheila Rocha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheila Rocha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheila Rocha. The network helps show where Cheila Rocha may publish in the future.

Co-authorship network of co-authors of Cheila Rocha

This figure shows the co-authorship network connecting the top 25 collaborators of Cheila Rocha. A scholar is included among the top collaborators of Cheila Rocha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheila Rocha. Cheila Rocha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hempel, Tim, Jonathan H. Shrimp, Nina Moor, et al.. (2025). Simulations and active learning enable efficient identification of an experimentally-validated broad coronavirus inhibitor. Nature Communications. 16(1). 6949–6949.

Arora, Prerna, Lu Zhang, Inga Nehlmeier, et al.. (2025). Host cell lectins ASGR1 and DC-SIGN jointly with TMEM106B confer ACE2 independence and imdevimab resistance to SARS-CoV-2 pseudovirus with spike mutation E484D. Journal of Virology. 99(2). e0123024–e0123024. 1 indexed citations

Rocha, Cheila, Thomas Neumann, Melanie Galla, et al.. (2024). A tetravalent bispecific antibody outperforms the combination of its parental antibodies and neutralizes diverse SARS-CoV-2 variants. Clinical Immunology. 260. 109902–109902. 1 indexed citations

Hoffmann, Markus, Lok-Yin Roy Wong, Prerna Arora, et al.. (2023). Omicron subvariant BA.5 efficiently infects lung cells. Nature Communications. 14(1). 3500–3500. 21 indexed citations

Schoger, Eric, Giulia Germena, Cheila Rocha, et al.. (2023). Single-cell transcriptomics reveal extracellular vesicles secretion with a cardiomyocyte proteostasis signature during pathological remodeling. Communications Biology. 6(1). 79–79. 10 indexed citations

Krüger, Nadine, Thales Kronenberger, Hang Xie, et al.. (2023). Discovery of Polyphenolic Natural Products as SARS-CoV-2 Mpro Inhibitors for COVID-19. Pharmaceuticals. 16(2). 190–190. 11 indexed citations

Sidarovich, Anzhalika, Nadine Krüger, Cheila Rocha, et al.. (2022). Host Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1. Viruses. 14(11). 2475–2475. 1 indexed citations

Arora, Prerna, Lu Zhang, Cheila Rocha, et al.. (2022). The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant. International Journal of Molecular Sciences. 23(22). 14057–14057. 4 indexed citations

Arora, Prerna, Lu Zhang, Nadine Krüger, et al.. (2022). SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodies. Cell Host & Microbe. 30(8). 1103–1111.e6. 29 indexed citations

10.

Arora, Prerna, Cheila Rocha, Amy Kempf, et al.. (2021). The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency. Cellular and Molecular Immunology. 18(12). 2673–2675. 29 indexed citations

11.

Krüger, Nadine, Cheila Rocha, Federico Armando, et al.. (2021). The Upper Respiratory Tract of Felids Is Highly Susceptible to SARS-CoV-2 Infection. International Journal of Molecular Sciences. 22(19). 10636–10636. 16 indexed citations

12.

Hoffmann, Markus, Nadine Krüger, Sebastian Schulz, et al.. (2021). The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic. Cell. 185(3). 447–456.e11. 557 indexed citations breakdown →

13.

Rocha, Cheila, Joana Duarte, Pedro Borrego, et al.. (2017). Potency of HIV-2-specific antibodies increase in direct association with loss of memory B cells. AIDS. 31(17). 2431–2433. 3 indexed citations

14.

Amaral, Andreia J., Jorge Andrade, Russell B. Foxall, et al.. (2016). mi RNA profiling of human naive CD 4 T cells links miR‐34c‐5p to cell activation and HIV replication. The EMBO Journal. 36(3). 346–360. 32 indexed citations

15.

Cunha-Santos, Catarina, Tiago N. Figueira, Pedro Borrego, et al.. (2016). Development of synthetic light-chain antibodies as novel and potent HIV fusion inhibitors. AIDS. 30(11). 1691–1701. 9 indexed citations

16.

Rocha, Cheila, Pedro Borrego, Inês Bártolo, et al.. (2013). Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response. Retrovirology. 10(1). 110–110. 9 indexed citations

17.

Bártolo, Inês, Pedro Borrego, Cheila Rocha, et al.. (2011). Genetic Diversity and Drug Resistance Profiles in HIV Type 1- and HIV Type 2-Infected Patients from Cape Verde Islands. AIDS Research and Human Retroviruses. 28(5). 510–522. 9 indexed citations

18.

Bártolo, Inês, Rui Bastos, Cheila Rocha, et al.. (2009). HIV-1 Genetic Diversity and Transmitted Drug Resistance in Health Care Settings in Maputo, Mozambique. JAIDS Journal of Acquired Immune Deficiency Syndromes. 51(3). 323–331. 24 indexed citations

19.

Borrego, Pedro, Cheila Rocha, Manuela Doroana, et al.. (2008). The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patients. Retrovirology. 5(1). 78–78. 19 indexed citations

20.

Bártolo, Inês, et al.. (2008). Highly divergent subtypes and new recombinant forms prevail in the HIV/AIDS epidemic in Angola: New insights into the origins of the AIDS pandemic. Infection Genetics and Evolution. 9(4). 672–682. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact